Skip to content
  • Careers
  • News
  • Contact Us
Top Bar
Facebook page opens in new window
Epilepsy Agency of the Big Bend (EABB)
Serving the Big Bend
Epilepsy Agency of the Big Bend (EABB)
  • What We Do
    • Who We Are
    • History
    • Stories of Hope
    • Request a Presentation
    • Board Applicant Form
  • About Epilepsy
    • Column 1
      • What is Epilepsy?
      • Seizure First Aid
      • Epilepsy Research
      • Prognosis
      • Treatment
      • HOBSCOTCH: Home Based Self-Management & Cognitive Training Changes Lives
    • Column 2
      • Epilepsy Self-Management at EABB
      • Epilepsy and Education
      • Epilepsy and Employment
      • Epilepsy and the Law
      • Epilepsy and Nutrition
      • Epilepsy and Tobacco Use
    • Column 3
      • Gender and Epilepsy
      • Mental Health Resources
      • Race, Ethnicity and Epilepsy
      • Stigma, Mental Health and Epilepsy
    • Column 4
      • Color, Light and Epilepsy
      • Famous People with Epilepsy
      • Driving with Epilepsy in Florida
  • Resources
    • Florida State Epilepsy Services Programs
    • Florida State Epilepsy Services Medication Program
    • Epilepsy Healthcare Providers
    • National Association of Epilepsy Centers: Florida
    • Patient Organizations
  • Calendar
  • News
DONATE
Search:
  • What We Do
    • Who We Are
    • History
    • Stories of Hope
    • Request a Presentation
    • Board Applicant Form
  • About Epilepsy
    • Resources
      • Florida State Epilepsy Services Programs
      • Florida State Epilepsy Services Medication Program
      • Epilepsy Healthcare Providers
      • National Association of Epilepsy Centers: Florida
      • Patient Organizations
    • Calendar
    • News

    Daily Archives: April 20, 2026

    You are here:
    1. Home
    2. 2026
    3. April
    4. 20

    TV Storylines Spotlight Ongoing Stigma and Misconceptions Around Epilepsy

    NewsBy BJ IacinoApril 20, 2026

    Recent TV storylines highlight key realities of epilepsy, including stigma, first aid misconceptions, and driving challenges. Learn more.

    New Phase III Data Strengthens Case for Azetukalner in Focal Epilepsy

    NewsBy BJ IacinoApril 20, 2026

    Xenon Pharmaceuticals reported positive Phase III results for Azetukalner at the American Academy of Neurology annual meeting, potentially shifting focal epilepsy treatment. Learn more.

    Copyright 2021. Epilepsy Association of the Big Bend
    Go to Top
    Translate »